CARM1-mediated Methylation of ASXL2 Impairs Tumor-suppressive Function of MLL3/COMPASS

Overview

Journal Sci Adv

Specialties Biology
Science

Date 2022 Oct 5

PMID 36197977

Authors

Zibo Zhao

Emily Jane Rendleman

Aileen Patricia Szczepanski

Marc Alard Morgan

Lu Wang

Ali Shilatifard

Affiliations

Soon will be listed here.

Abstract

An imbalance in the activities of the Polycomb and Trithorax complexes underlies numerous human pathologies, including cancer. The BRCA1 associated protein-1 (BAP1) deubiquitinase negatively regulates Polycomb activity and recruits the Trithorax histone H3K4 methyltransferase, mixed-lineage leukemia protein 3 (MLL3) within Complex Proteins Associated with Set1 (COMPASS), to the enhancers of tumor suppressor genes. We previously demonstrated that the BAP1-MLL3 pathway is mutated in several cancers, yet how BAP1 recruits MLL3 to its target loci remains an important unanswered question. We demonstrate that the ASXL2 subunit of the BAP1 complex mediates a direct interaction with MLL3/COMPASS. ASXL2 loss results in decreased MLL3 occupancy at enhancers and reduced BAP1-MLL3 target gene expression. Interaction between ASXL2 and MLL3 is negatively regulated by protein arginine methyltransferase 4 (PRMT4/CARM1), which methylates ASXL2 at R639/R641. ASXL2 methylation blocks binding to MLL3 and impairs the expression of MLL3/COMPASS-dependent genes. This previously unidentified transcriptional repressive function of CARM1 provides insight into the BAP1/MLL3-COMPASS axis and reveals a potential cancer therapeutic target.

Citing Articles

Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance.

Hong X, Huang C, Qian H, Ding C, Liu F, Hong H Nat Commun. 2025; 16(1):87.

PMID: 39747898 PMC: 11697449. DOI: 10.1038/s41467-024-55769-8.

Integrative analysis of ASXL family genes reveals ASXL2 as an immunoregulatory molecule in head and neck squamous cell carcinoma.

Liu Q, Zhu W, Tang C, Liu W, Luo X Sci Rep. 2024; 14(1):31368.

PMID: 39732849 PMC: 11682168. DOI: 10.1038/s41598-024-82815-8.

Arginine methylation-dependent TRIM47 stability mediated by CARM1 promotes the metastasis of hepatocellular carcinoma.

Tang Y, Meng X, Luo X, Yao W, Tian L, Zhang Z Cell Death Discov. 2024; 10(1):477.

PMID: 39567506 PMC: 11579460. DOI: 10.1038/s41420-024-02244-4.

Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).

Qu P, Li L, Jin Q, Liu D, Qiao Y, Zhang Y Int J Mol Med. 2024; 54(5).

PMID: 39301658 PMC: 11414529. DOI: 10.3892/ijmm.2024.5428.

Dysregulation of arginine methylation in tumorigenesis.

Li X, Song Y, Mu W, Hou X, Ba T, Ji S Front Mol Biosci. 2024; 11:1420365.

PMID: 38911125 PMC: 11190088. DOI: 10.3389/fmolb.2024.1420365.

References

Greenblatt S, Man N, Hamard P, Asai T, Karl D, Martinez C . CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis. Cancer Cell. 2018; 33(6):1111-1127.e5. PMC: 6191185. DOI: 10.1016/j.ccell.2018.05.007. View

Hu D, Gao X, Morgan M, Herz H, Smith E, Shilatifard A . The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol Cell Biol. 2013; 33(23):4745-54. PMC: 3838007. DOI: 10.1128/MCB.01181-13. View

Baymaz H, Fournier A, Laget S, Ji Z, Jansen P, Smits A . MBD5 and MBD6 interact with the human PR-DUB complex through their methyl-CpG-binding domain. Proteomics. 2014; 14(19):2179-89. DOI: 10.1002/pmic.201400013. View

Bedford M, Frankel A, Yaffe M, Clarke S, Leder P, Richard S . Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J Biol Chem. 2000; 275(21):16030-6. DOI: 10.1074/jbc.M909368199. View

Zhang Y, Liu T, Meyer C, Eeckhoute J, Johnson D, Bernstein B . Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9(9):R137. PMC: 2592715. DOI: 10.1186/gb-2008-9-9-r137. View

Wang L, Zeng H, Wang Q, Zhao Z, Boyer T, Bian X . MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugs. Sci Adv. 2015; 1(9):e1500463. PMC: 4646802. DOI: 10.1126/sciadv.1500463. View

Micol J, Pastore A, Inoue D, Duployez N, Kim E, Chun-Wei Lee S . ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia. Nat Commun. 2017; 8:15429. PMC: 5454368. DOI: 10.1038/ncomms15429. View

Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S . Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet. 2011; 43(9):875-8. PMC: 5373841. DOI: 10.1038/ng.907. View

Dey A, Seshasayee D, Noubade R, French D, Liu J, Chaurushiya M . Loss of the tumor suppressor BAP1 causes myeloid transformation. Science. 2012; 337(6101):1541-6. PMC: 5201002. DOI: 10.1126/science.1221711. View

10.

Carbone M, Ferris L, Baumann F, Napolitano A, Lum C, Flores E . BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012; 10:179. PMC: 3493315. DOI: 10.1186/1479-5876-10-179. View

11.

Szczepanski A, Zhao Z, Sosnowski T, Goo Y, Bartom E, Wang L . ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. Genome Med. 2020; 12(1):63. PMC: 7362484. DOI: 10.1186/s13073-020-00760-3. View

12.

Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

13.

Guccione E, Richard S . The regulation, functions and clinical relevance of arginine methylation. Nat Rev Mol Cell Biol. 2019; 20(10):642-657. DOI: 10.1038/s41580-019-0155-x. View

14.

Fursova N, Turberfield A, Blackledge N, Findlater E, Lastuvkova A, Huseyin M . BAP1 constrains pervasive H2AK119ub1 to control the transcriptional potential of the genome. Genes Dev. 2021; 35(9-10):749-770. PMC: 8091973. DOI: 10.1101/gad.347005.120. View

15.

Machida Y, Machida Y, Vashisht A, Wohlschlegel J, Dutta A . The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem. 2009; 284(49):34179-88. PMC: 2797188. DOI: 10.1074/jbc.M109.046755. View

16.

Black J, Van Rechem C, Whetstine J . Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell. 2012; 48(4):491-507. PMC: 3861058. DOI: 10.1016/j.molcel.2012.11.006. View

17.

Zou W, Rohatgi N, Brestoff J, Moley J, Li Y, Williams J . Myeloid-specific Asxl2 deletion limits diet-induced obesity by regulating energy expenditure. J Clin Invest. 2020; 130(5):2644-2656. PMC: 7190927. DOI: 10.1172/JCI128687. View

18.

Morgan M, Shilatifard A . Chromatin signatures of cancer. Genes Dev. 2015; 29(3):238-49. PMC: 4318141. DOI: 10.1101/gad.255182.114. View

19.

Carbone M, Yang H, Pass H, Krausz T, Testa J, Gaudino G . BAP1 and cancer. Nat Rev Cancer. 2013; 13(3):153-9. PMC: 3792854. DOI: 10.1038/nrc3459. View

20.

McBride A, Silver P . State of the arg: protein methylation at arginine comes of age. Cell. 2001; 106(1):5-8. DOI: 10.1016/s0092-8674(01)00423-8. View